Interferon alfa-2b: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Interferon alfa-2b}} | {{Interferon alfa-2b}} | ||
'''''For patient information, click <u>[[ | '''''For patient information, click <u>[[Interferon alfa-2b (patient information)|here]]'''''</u>. | ||
{{CMG}} | {{CMG}} | ||
| Line 23: | Line 23: | ||
''' [[Interferon alfa-2b description|Description]]''' | ''' [[Interferon alfa-2b description|Description]]''' | ||
'''| [[Interferon alfa-2b clinical pharmacology|Clinical Pharmacology]]''' | '''| [[Interferon alfa-2b clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[Interferon alfa-2b indications and usage|Indications and Usage]]''' | '''| [[Interferon alfa-2b indications and usage|Indications and Usage]]''' | ||
'''| [[Interferon alfa-2b contraindications|Contraindications]]''' | '''| [[Interferon alfa-2b contraindications|Contraindications]]''' | ||
| Line 30: | Line 29: | ||
'''| [[Interferon alfa-2b drug interactions|Drug Interactions]]''' | '''| [[Interferon alfa-2b drug interactions|Drug Interactions]]''' | ||
'''| [[Interferon alfa-2b overdosage|Overdosage]]''' | '''| [[Interferon alfa-2b overdosage|Overdosage]]''' | ||
'''| [[Interferon alfa-2b dosage and administration|Dosage and Administration]]''' | '''| [[Interferon alfa-2b dosage and administration|Dosage and Administration]]''' | ||
'''| [[Interferon alfa-2b how supplied|How Supplied]]''' | '''| [[Interferon alfa-2b how supplied|How Supplied]]''' | ||
Revision as of 20:14, 8 January 2014
For patient information, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Interferon alfa-2b is an antiviral drug discovered and marketed by Schering-Plough under the tradename Intron-
®. It has been used for a wide range of indications, including viral infections and cancers. This drug is approved around the world for the treatment of chronic hepatitis C, chronic hepatitis B, hairy cell leukemia, chronic myelogenous leukemia, multiple myeloma, follicular lymphoma, carcinoid tumor, and malignant melanoma.
Category
Antiviral
US Brand Names
INTRON A®
FDA Package Insert
Description | Clinical Pharmacology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Dosage and Administration | How Supplied | Labels and Packages